WallStreetZenWallStreetZen

NASDAQ: NEUP
Neuphoria Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neuphoria Therapeutics earnings were -$3.9M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest NEUP earnings report on Dec 31, 2025 announced Q4 2025 earnings of $1.3M, down 119.3% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, NEUP reported annual earnings of -$243.2k, with -97.6% growth.

NEUP earnings history

Current Revenue
$10.1M
Current Earnings
-$3.8M
Current Profit Margin
-37.8%

NEUP Return on Equity

Current Company
-26%
Current Industry
13.6%
Current Market
31.7%
NEUP's Return on Equity (-26%)... subscribe to Premium to read more.
High Return on Equity Performance

NEUP Return on Assets

Current Company
-18.4%
Current Industry
5.3%
NEUP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NEUP announces earnings.

NEUP Return on Capital Employed

Current Company
-17.88%
Current Industry
14.4%
NEUP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NEUP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NEUP-$3.76M-$3.93MN/A-$2.25
DARE-$16.36M-$17.46MN/A-$1.88
XCUR-$8.71M-$9.23MN/A-$3.70
IGC-$5.88M-$6.45MN/A-$0.07
MRKR-$14.25M-$14.30MN/A-$1.23
View Top Biotech Stocks

Neuphoria Therapeutics Earnings Reports & History FAQ

What were Neuphoria Therapeutics's earnings last quarter?

Neuphoria Therapeutics (NASDAQ: NEUP) reported Q4 2025 earnings per share (EPS) of $0.28, up 135.99% year over year. Total NEUP earnings for the quarter were $1.25 million. In the same quarter last year, Neuphoria Therapeutics's earnings per share (EPS) was -$0.76.

If you're new to stock investing, here's how to buy Neuphoria Therapeutics stock.

Is Neuphoria Therapeutics profitable or losing money?

As of the last Neuphoria Therapeutics earnings report, Neuphoria Therapeutics is currently losing money. Neuphoria Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$3.80 million, a 25.49% decrease year over year.

What was NEUP's earnings growth in the past year?

As of Neuphoria Therapeutics's earnings date in Q1 2026, Neuphoria Therapeutics's earnings has grown year over year. NEUP earnings in the past year totalled -$3.93 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.